Healthcare and Wellness Investment by NDude Labs in SuperMush

Healthcare and wellness investment firm NDude Labs, based in India and the US, has spearheaded a $3 million Series A funding round in the US-based functional wellness brand SuperMush. This new investment is intended to broaden SuperMush’s product offerings, enhance formulations, and fortify its team and customer support infrastructure.

About SuperMush

Established in 2022 by Alli Schaper and Brian Friedman, SuperMush creates wellness products that incorporate ingredients like nootropics, adaptogens, and functional mushrooms. The product range features items such as Shilajit, Creatine, and Lion’s Mane gummies.

Expansion of SuperMush

In the past year, SuperMush has successfully made its way into over 1,000 Target stores. Currently, it boasts a retail footprint in more than 2,000 locations across the US, including Target and Sprouts, in addition to selling products through its website and Amazon.

Future Plans

The brand aims to enhance its presence across retail, direct-to-consumer, and marketplace channels while also focusing on the development of new products and formulations.

Investment Background of NDude Labs

For NDude Labs, this funding comes on the heels of its recent investment in Nutriventia, a company that deals with nutraceutical ingredients. The firm is committed to investing in healthcare and wellness enterprises across both India and the US.